Chemotherapy is never a good solution in threating prostate cancer because there are several implications that could be caused. It can cause several implications and even appearance of some other diseases. Alopecia and erectile dysfunction are most common. We consider ourselves as a company that cares for its clients, especially for men with prostate cancer because of its problematic nature and its expansion.
Underlying pathology very often indicates serious questioning about cancer recurrance. Appearance of some other problems may indicate that there could be some possibilities for cancer developing. Some studies can resolve many problems.
Statistic in Germany
Reserchers in Germany said that the most dangerous ingredient in drugs like Viagra is phosphodiesterase type 5 inhibitors (PDE5i). Their results said that it can indicate on some relations between ED drugs consuming and prostate cancer recurrance. after certain results doctors were reconsidering some former opinions. The study was formed of 4752 men. All of them had certain signs of cancer recurrance. This study shooked public opinion.
Doctors in Sweden and US
American urologist Stacy Loeb MD, from New York University, and her team said the research by the German scientists interested her very much and she and her team decided to expand this research and see if they could find another angle. They worked together with Swedish institutions – nationwide population-based National Prostate Cancer Register, and the Prescribed Drug Register.
Considering every angle of this project, they concluded that there is no more risk of prescribing medicins like My Canadian Pharmacy has to offer:
- tadalafil (Cialis),
- sildenafil (Viagra) and;
- vardenafil (Levitra).
Statistical resultas showed that only 4.8 men of a total 6060 subjects had some positive signs of prostate cancer recurrance after taking drugs for ED problems.
My Canadian Pharmacy analised both studies, with German reserchers and with Dr. Loeb reserch team. The German study has had strong supporters, one of whom is Dr. Thorsten Schlomm who works at the Martini-Clinic Prostate Cancer Center at the University Medical Center Hamburg-Eppendorf. Another study provided at that time by Italian scientists supported Dr. Loeb’s findings. Using the Italian database they also discovered that the link between erectile dysfunction drugs and the recurrence of prostate cancer was marginal.
According to this, public opinion can feel safe and relaxed. Hence it has been ruled out that erectile dysfunction drugs are not linked to the biochemical recurrence of prostate cancer in men. Doctors and patients alike can breathe a sigh of relief.